Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146961 · ClinicalTrials.gov registry record
The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
A clinical trial, sponsored by Research Insight.
- Completed
- Registry status
- 59
- Enrollment target
NCT04146961 is a clinical trial that has completed, run by Research Insight. The registered enrollment target is 59 participants.
The verdict
NCT04146961 has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
Prospective survey study of patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric intraocular lens in both eyes.
Interventions
- DEVICE Alcon PanOptix or PanOptix Toric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2019-10-05 |
| Est. Completion | 2020-07-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04146961
The ClinicalTrials.gov registry entry for NCT04146961 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Insight, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alcon PanOptix or PanOptix Toric IOL is the first listed.
NCT04146961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04146961 about?
NCT04146961 is a clinical study titled "The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance". Prospective survey study of patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric intraocular lens in both eyes.
What is the current status of trial NCT04146961?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2019-10-05. Estimated completion is 2020-07-21.
What interventions are being tested in trial NCT04146961?
The interventions under investigation include: Alcon PanOptix or PanOptix Toric IOL (DEVICE).
Who is sponsoring clinical trial NCT04146961?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.